Superstring Capital Management’s LakeShore Biopharma LSB Stock Holding History

Superstring Capital Management’s Portfolio LSB Stock Details LSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-30,792	Closed	-$31.4K	–	52
2025 Q2	$31.4K	Hold	30,792	–	–	0.04%	36
2025 Q1	$74.5K	Hold	30,792	–	–	0.09%	34
2024 Q4	$106K	Hold	30,792	–	–	0.09%	39
2024 Q3	$212K	Hold	30,792	–	–	0.19%	27
2024 Q2	$200K	Hold	30,792	–	–	0.25%	36
2024 Q1	$216K	Hold	30,792	–	–	0.14%	36
2023 Q4	$166K	Buy	+30,792	New	+$177K	0.12%	30

Other funds holding LSB

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Superstring Capital Management's LSB Position: Q3 2025 in Review

Superstring Capital Management sold out of LakeShore Biopharma (LSB) in Q3 2025, closing a stake of 30,792 shares — an estimated $31.4K sold.

Superstring Capital Management first reported a position in LSB in Q4 2023 and held it in 7 quarters. The position peaked at $216K in Q1 2024. 1 fund tracked by Wall St. Rank holds LSB as of Q3 2025.

Superstring Capital Management reported no remaining LakeShore Biopharma position as of Q3 2025 after selling out during the quarter.
Superstring Capital Management sold 30,792 LakeShore Biopharma shares in Q3 2025, an estimated $31.4K.
Superstring Capital Management first reported a position in LakeShore Biopharma in Q4 2023 and held it in 7 quarters.
Superstring Capital Management's LakeShore Biopharma position peaked at $216K in Q1 2024.
1 fund tracked by Wall St. Rank held LakeShore Biopharma as of Q3 2025.

Based on Superstring Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.